Home » Topics » Conferences

Conferences
RSS

5-LO inhibitor under evaluation at SKB

Dec. 19, 1996

DuPont Merck developing atypical antipsychotic

Dec. 19, 1996

DuPont Merck reports ester prodrugs for glaucoma

Dec. 19, 1996

Innapharma reports novel antidepressant

Dec. 19, 1996

New bile acid transporter inhibitors in preclinical testing at Searle

Dec. 16, 1996

Oral butyrate prodrug in preclinical testing at Vertex

Dec. 13, 1996

DuPont Merck evaluates new candidate cognition enhancer

Dec. 13, 1996

DuPont Merck reports pharmacokinetic data for novel gpIIb/IIIa antagonist

Dec. 13, 1996

New ET antagonist in preclinical testing at Parke-Davis

Dec. 13, 1996

New HIV-1 protease inhibitor in development at LG Chemical

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.